Lack of activity of allogeneic stem cell transplantation with reduced-intensity conditioning regimens in advanced sarcomas [4]

Bone Marrow Transplantation

Volumn 35, Issue 4, 2005, Pages 421-422

  Castagna, L ^a   Sarina, B ^a   Todisco, E ^a   Bramanti, S ^a   Bertuzzi, A ^a   Zuradelli, M ^a   Santoro, A ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADOPTIVE IMMUNOTHERAPY; ADULT; ADVANCED CANCER; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; LETTER; MALE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SIBLING; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT INDICATION;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; SARCOMA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 14644423333     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704774     Document Type: Letter

References (6)

1. Santoro A. Advanced soft tissue sarcoma: how many more trials with anthracyclines and ifosfamide. Ann Oncol 1999; 10: 151-154.
2. Van Glabekke M, van Oosterom AT, Oosterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens - a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 1999; 17: 150-157.
3. Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750-758.
4. Worley BS, van den Broeke LT, Goletz TJ et al. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res 2001; 61: 6868-6875.
5. Pedrazzoli P, Da Prada GA, Giorgiani G et al. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies. Cancer 2002; 94: 2409-2415.
6. Makimoto A, Kami M, Mineishi R. Reduced-intensity allogeneic stem-cell transplantation (RIST) for patients including children with refractory sarcomas. Proc ASCO 2003; 22: 3355.